Actively Recruiting
GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy
Led by University of Sao Paulo · Updated on 2025-02-03
28
Participants Needed
2
Research Sites
53 weeks
Total Duration
On this page
Sponsors
U
University of Sao Paulo
Lead Sponsor
T
Thomas Jefferson University
Collaborating Sponsor
AI-Summary
What this Trial Is About
We aim to determine if targeted high-definition transcranial direct current stimulation (HD-tDCS) can safely correct errors in visual verticality perception in patients after stroke affecting either hemisphere.
CONDITIONS
Official Title
GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Supratentorial ischemic stroke diagnosed by neuroimaging and clinical analysis
- Clinically stable with stable vital signs for 24 hours and no recent chest pain or significant arrhythmia
- Normal or corrected-to-normal vision
- No previous experience with HD-tDCS
- Ability to provide informed consent (patient or legal representative)
- Ability to comply with the intervention and assessment schedule
- Presence of visual verticality misperception
You will not qualify if you...
- Migraine
- Pregnancy
- Pacemakers
- Seizures
- Claustrophobia
- Transient ischemic attack
- Other neurological disorders
- Psychiatric disorders
- Sensitive scalp or prior brain surgery
- Severe carotid atherosclerotic disease (stenosis ≥ 70%)
- Presence of metal implants, cardiac pacemakers, or claustrophobia
- Diagnosis of COVID-19 or other infectious disease requiring isolation
- Uncontrolled medical problems such as terminal cancer or kidney disease
- Left-handed or mixed-handed individuals
- Peripheral vestibular deficits observed in screening tests
- Prior musculoskeletal disorders affecting alignment and balance (e.g., moderate to severe scoliosis, torticollis)
- Cognitive dysfunction with Mini-Mental State Examination score below 23
- Global or Wernicke's aphasia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Ribeirão Preto Medical School, University of São Paulo
Ribeirão Preto, São Paulo, Brazil, 14015160
Actively Recruiting
2
University of São Paulo, Ribeirão Preto Medical School
Ribeirão Preto, São Paulo, Brazil, 14049-900
Not Yet Recruiting
Research Team
T
Taiza G. S. Edwards, PhD
CONTACT
L
Lizanilda Albuquerque, BSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here